YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Illumina, BGI Battle Over Complete Genomics

November 27, 2012 | The fight for Complete Genomics is not over. BGI and Illumina have both submitted letters arguing that their offer is a better fit to the Complete Genomics board. Illumina has offered a better price, and pointed out that an Illumina-Complete Genomics deal would not be subject to foreign investment oversight. BGI accused Illumina of being anticompetitive and making false allegations. Nature News
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.